AMCOGEN ALLIANCE LIFESCIENCES PRIVATE LIMITED

AMCOGEN ALLIANCE LIFESCIENCES PRIVATE LIMITED is a company based in India operating in the biopharmaceutical sector. It is primarily involved in the commercialization, marketing, and distribution of innovative medicines and therapies. The company plays a role in bringing advanced biopharmaceutical products, often developed by its global parent or partner Amgen, to the Indian market, serving patients and healthcare professionals. Its activities typically include import, supply chain management, sales, and marketing of these specialized pharmaceutical products within India.

The company is primarily a trader/distributor.

AMCOGEN ALLIANCE LIFESCIENCES PRIVATE LIMITED is involved in the sale and distribution of Amgen's biopharmaceutical products in India. These products address various therapeutic areas, including oncology, cardiovascular disease, bone health, and inflammatory diseases.

The products that AMCOGEN ALLIANCE LIFESCIENCES PRIVATE LIMITED would be involved in selling or distributing in India include:

Prolia (Denosumab)

Xgeva (Denosumab)

Evenity (Romosozumab)

Repatha (Evolocumab)

Otezla (Apremilast)

Kyprolis (Carfilzomib)

Neulasta (Pegfilgrastim)

Enbrel (Etanercept)

Vectibix (Panitumumab)

Blincyto (Blinatumomab)

Aimovig (Erenumab)

Lumakras/Lumykras (Sotorasib)